Docket Room
H 2472·MA·house

An Act protecting patient safety regarding non-FDA approved drugs

FailedFiled Feb 27, 2025
Sponsor: Kathy LaNatra (D)
Latest Action

Accompanied a study order, see H5234

Mar 16, 2026

Summary

The bill forbids any retail pharmacy in Massachusetts from selling compounded medications to anyone other than the patient for whom they were prepared. It also requires detailed labeling on compounded drugs and gives the state pharmacy board authority to fine, suspend, or revoke licenses for violations. The goal is to protect patient safety by ensuring compounded drugs are used only as intended.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when H 2472 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice